Scion to partner Strand in clinical genomics
Scion, one of India's leading brand consulting and strategic brand incubation firms, on Monday said it will work closely with Strand Life Sciences on its branding and marketing program, which includes the development of brand positioning, business and communication strategy, brand identity, integrated activation plan and an exciting creative execution targeted at the medical fraternity.
The brand strategy focusses on the idea that Strand Centers offer deeper insights that help consumers and the healthcare fraternity make more informed decisions.
The outlook is based on the fact that Strand Life Sciences is a pioneering company with decades of expertise, proven track record, and intellect that can provide authoritative insights to doctors in the emerging field of personalised medicine.
"In several of the leading hospitals in India, a revolution in genomic diagnostics leading to personalised medicine is taking place. This new DNA-based testing is the new frontier of medical science and is set to alter the clinical practices of diagnosis and treatment of patients" the company said.
"Genomics is a game changer in the field of diagnostics, and Strand is perhaps the only credible and knowledgeable player to bring such an advanced and incisive program to hospitals and doctors," said Ramesh Rao, Managing Director, Scion.
"Partnering with Strand is in line with our focus of working with brands that create meaning and value for the larger good of society," said Rao.
The Strand brand attributes are humanitarian, expertise, knowledge sharing, futuristic and pioneering. The logo designed by Scion is a creative representation of four chromosomes in a graphic form depicting people and personalised medicine.
Thiru Reddy, VP. Strand genomics, said, "Our goal is bring the power of genomic to improve clinical outcomes. We want to set and tow stringent standards of knowledge delivery and harness our breadth of expertise in educating and assisting the medical community into adopting this exciting new medical tool."
According to Vijay Chandru, Co- founder and Chairman of Strand, "Through this association, we seek to leverage Scion's track record in creating a brand that successfully reflects the 'bench-to-bedside' revolution of gene-based diagnostics and personalized medicine that we are bringing to our home markets. Scion goes beyond brand partnership, and is participating in in the articulation of business and marketing strategies."
(Posted on 23-12-2013)